Foreign Policy | September 15, 2020
Read the PublicationIn one of its latest strikes against global solidarity in the midst of the COVID-19 pandemic, the administration of U.S. President Donald Trump has declared that it will not participate in the COVID-19 Vaccine Global Access (COVAX) Facility, a global partnership that aims to support the development of a vaccine and share access to it. Trump apparently prefers, instead, a go-it-alone approach that could undermine Americans’ access to an eventual vaccine and disrupt efforts to ensure equity in its global distribution.